Institutions / Vestal Point Capital, LP / Holdings
Back to Vestal Point Capital, LP

Vestal Point Capital, LP

All holdings · as of Dec 31, 2025

75 positions

CompanyClassValueShares% of portfolio
MacroGenics, Inc.—$450.8K280,0000.0%
REGENXBIO Inc.—$489.6K34,0000.0%
Tenax Therapeutics, Inc.—$651.4K53,4390.0%
Alector, Inc.—$1.18M755,0000.0%
FATE THERAPEUTICS INC—$1.69M1,725,0000.1%
OnKure Therapeutics, Inc.—$1.84M635,0000.1%
Black Diamond Therapeutics, Inc.BDTXCommon Stock$2.11M870,0000.1%
Dyne Therapeutics, Inc.—$2.35M120,0000.1%
Structure Therapeutics Inc.GPCRADR$2.43M35,0000.1%
Sutro Biopharma, Inc.—$2.81M243,0000.1%
Passage BIO, Inc.PASGCommon Stock$3.60M305,0000.1%
Rezolute, Inc.—$3.98M1,686,0000.1%
LENZ Therapeutics, Inc.—$4.40M275,0000.2%
Nuvalent, Inc.—$4.63M46,0000.2%
NYXOAH SA—$5.09M1,107,0000.2%
Mirum Pharmaceuticals, Inc.—$5.21M66,0000.2%
DBV TECHNOLOGIES S.A.DBVTADR$5.75M300,0000.2%
Voyager Therapeutics, Inc.—$5.80M1,475,0000.2%
GILEAD SCIENCES, INC.—$6.14M50,0000.2%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$6.76M385,0000.2%
NovoCure Ltd—$6.79M525,0000.2%
Tectonic Therapeutic, Inc.TECXCommon Stock$6.84M328,0000.3%
MYRIAD GENETICS INC—$7.52M1,223,0000.3%
Denali Therapeutics Inc.—$7.68M465,0000.3%
Definium Therapeutics Inc—$8.53M637,0000.3%
AGIOS PHARMACEUTICALS, INC.—$8.85M325,0000.3%
enGene Therapeutics Inc.—$9.53M1,055,0000.3%
Savara IncSVRACommon Stock$9.68M1,606,0000.4%
Fulcrum Therapeutics, Inc.—$10.74M950,0000.4%
Monte Rosa Therapeutics, Inc.—$12.15M775,0000.4%
BRISTOL MYERS SQUIBB CO—$13.48M250,0000.5%
Zimmer Biomet Holdings Inc—$13.49M150,0000.5%
REPLIGEN CORP—$13.60M83,0000.5%
GERON CORP—$14.94M11,320,0000.5%
Penumbra Inc—$15.55M50,0000.6%
BIOCRYST PHARMACEUTICALS INC—$17.55M2,250,0000.6%
CRESCENT BIOPHARMA, INC.—$17.79M1,500,0000.7%
Beta Bionics, Inc.—$18.28M600,0000.7%
Upstream Bio, Inc.UPBCommon Stock$19.55M720,0000.7%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$20.31M585,0000.7%
ZYMEWORKS INC.—$22.78M865,0000.8%
Revolution Medicines, Inc.—$23.50M295,0000.9%
Lantheus Holdings, Inc.—$23.96M360,0000.9%
Xenon Pharmaceuticals Inc.—$26.89M600,0001.0%
Vera Therapeutics, Inc.—$27.85M550,0001.0%
KalVista Pharmaceuticals Inc—$30.52M1,890,0001.1%
Scholar Rock Holding Corp—$30.84M700,0001.1%
Celldex Therapeutics, Inc.—$31.64M1,165,0001.2%
Solid Biosciences Inc.SLDBCommon Stock$32.80M5,815,0001.2%
Rapport Therapeutics, Inc.RAPPCommon Stock$33.68M1,110,0001.2%
← PrevPage 1 of 2Next →